Repeatability of central and peripheral eye length and choroidal thickness measurements in healthy subjects.
Recruiting
- Conditions
- Eye lengthChoroidal thickness
- Registration Number
- ACTRN12618001536257
- Lead Sponsor
- Brien Holden Vision Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence choroidal thickness in healthy subjects as studied in ACTRN12618001536257?
How do peripheral eye length measurements compare to central measurements in predicting ocular health outcomes?
Are there specific biomarkers associated with variations in choroidal thickness and eye length in ACTRN12618001536257?
What are the potential adverse events linked to repeated ocular imaging in healthy volunteers?
How do current imaging technologies for choroidal thickness and eye length compare in clinical trials sponsored by Brien Holden Vision Institute?